Previous close | 34.21 |
Open | 34.49 |
Bid | 0.00 x 800 |
Ask | 0.00 x 900 |
Day's range | 34.02 - 35.06 |
52-week range | 28.03 - 45.98 |
Volume | |
Avg. volume | 693,507 |
Market cap | 3.301B |
Beta (5Y monthly) | 1.50 |
PE ratio (TTM) | 67.84 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Amazon’s comprehensive family building benefit offered through Progyny to be recognized at RESOLVE’s Night of Hope GalaNEW YORK, Aug. 22, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, today announced their nearly five-year partnership with Amazon has reached a milestone number of more than 30,000 individuals and families being supported on their family building journeys. Since 2019, A
Integrative approach with leading providers Gennev and Midi Health to advance equitable and accessible workplace support for individuals experiencing menopause symptomsNEW YORK, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, today announced the strategic expansion of its extensive managed reproductive health network to include specialized providers of menopause care. Progyny’s
Reports Record Quarterly Revenue of $279.4 Million, Reflecting 43% Growth Over the Prior Year PeriodAchieves Record Quarterly Operating Cash Flow of $76.0 MillionRaises Full Year Revenue and Earnings GuidanceContinuing to See Strong Employer Demand for Fertility and Family Building Solutions NEW YORK, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) (“Progyny” or the “Company”), a leading benefits management company specializing in fertility and family building benefits solutions,